TP53 and essential thrombocythemia: An adverse prognostic relevance of some of them (SH2B3/LNK, SF3B1, U2AF1, TP53, IDH2, and EZH2) on overall, leukemia-free and myelofibrosis-free survival of ET pts was recently demonstrated [70, 73–75].